Sanderling Venture Partners VI LP is 10% at Pacira Pharmaceuticals, Inc. (PCRX). They have made 4 open-market trades across 2 companies since 2011, most recently 2024-11-01.
CIK 0001306717
3 open-market purchases totalling $3.2M since 2011, against 1 sale. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.